A US patent lasts 20 years from filing [1]. A study of 264 small-molecule drugs that faced new generic competition
How Long Do Drug Patents Last? 20 Years on Paper, About 14 in Practice Read Post »
Generic drugs perform better financially if they get to market first. The advantage is amplified if they get there more than one month ahead of competitors.
1. The Opportunity in Numbers: Patent Cliff Sizing and Market Structure Global Market Scale and Growth Trajectory The global generic
Generic Drug Market Entry: The Complete Analyst’s Playbook for Patent Cliff Profits Read Post »
Every year, dozens of brand-name drugs approach the end of their patent life with billions in annual revenue at stake.
Tentative Drug Approvals: The Definitive Generic Entry Forecasting Playbook Read Post »
Every year, the U.S. pharmaceutical market transfers hundreds of billions of dollars in revenue from branded monopolies to generic competitors.
Information contained in expired drug patents can be invaluable to researchers developing new products, but caution is required to avoid legal problems.
How abandoned and expired patents in pharmaceutical manufacturing reveal synthesis routes, competitor strategy, and biosimilar opportunities your R&D team is
Expired Pharma Patents: The $356 Billion Intelligence Asset Most Companies Ignore Read Post »
The Anomaly That Keeps Paying Here is a fact that surprises most people who work outside drug regulatory affairs: hundreds
How to use price erosion curves, Paragraph IV filings, Orange Book patent analysis, and biosimilar IP valuation to build a
Generic Entry Pricing: The Complete Drug Price Data Playbook for Portfolio Managers Read Post »
Sign in or create a free account to read this DrugPatentWatch article
